6-(chloromethyl)-N-[(4-chlorophenyl)methyl]-1-[2-(3,3-dimethylazetidin-1-yl)-2-oxoethyl]-2-oxo-1,8-naphthyridine-3-carboxamide;N-[(4-chlorophenyl)methyl]-1-[2-(3,3-dimethylazetidin-1-yl)-2-oxoethyl]-6-(imidazol-1-ylmethyl)-2-oxo-1,8-naphthyridine-3-carboxamide;1H-imidazole

C54H55Cl3N12O6 — CID 158180565

IUPAC6-(chloromethyl)-N-[(4-chlorophenyl)methyl]-1-[2-(3,3-dimethylazetidin-1-yl)-2-oxoethyl]-2-oxo-1,8-naphthyridine-3-carboxamide;N-[(4-chlorophenyl)methyl]-1-[2-(3,3-dimethylazetidin-1-yl)-2-oxoethyl]-6-(imidazol-1-ylmethyl)-2-oxo-1,8-naphthyridine-3-carboxamide;1H-imidazole
SMILESCC1(C)CN(C(=O)Cn2c(=O)c(C(=O)NCc3ccc(Cl)cc3)cc3cc(CCl)cnc32)C1.CC1(C)CN(C(=O)Cn2c(=O)c(C(=O)NCc3ccc(Cl)cc3)cc3cc(Cn4ccnc4)cnc32)C1.c1c[nH]cn1
InChIInChI=1S/C27H27ClN6O3.C24H24Cl2N4O3.C3H4N2/c1-27(2)15-33(16-27)23(35)14-34-24-20(9-19(12-30-24)13-32-8-7-29-17-32)10-22(26(34)37)25(36)31-11-18-3-5-21(28)6-4-18;1-24(2)13-29(14-24)20(31)12-30-21-17(7-16(9-25)11-27-21)8-19(23(30)33)22(32)28-10-15-3-5-18(26)6-4-15;1-2-5-3-4-1/h3-10,12,17H,11,13-16H2,1-2H3,(H,31,36);3-8,11H,9-10,12-14H2,1-2H3,(H,28,32);1-3H,(H,4,5)
InChIKeyFYNMXVJCDVPETM-UHFFFAOYSA-N
MW1074.47 g/mol
LogP7.09
Rot. Bonds13

About 6-(chloromethyl)-N-[(4-chlorophenyl)methyl]-1-[2-(3,3-dimethylazetidin-1-yl)-2-oxoethyl]-2-oxo-1,8-naphthyridine-3-carboxamide;N-[(4-chlorophenyl)methyl]-1-[2-(3,3-dimethylazetidin-1-yl)-2-oxoethyl]-6-(imidazol-1-ylmethyl)-2-oxo-1,8-naphthyridine-3-carboxamide;1H-imidazole

6-(chloromethyl)-N-[(4-chlorophenyl)methyl]-1-[2-(3,3-dimethylazetidin-1-yl)-2-oxoethyl]-2-oxo-1,8-naphthyridine-3-carboxamide;N-[(4-chlorophenyl)methyl]-1-[2-(3,3-dimethylazetidin-1-yl)-2-oxoethyl]-6-(imidazol-1-ylmethyl)-2-oxo-1,8-naphthyridine-3-carboxamide;1H-imidazole (PubChem CID 158180565) has the molecular formula C54H55Cl3N12O6 and a molecular weight of 1074.47 g/mol. Its IUPAC name is 6-(chloromethyl)-N-[(4-chlorophenyl)methyl]-1-[2-(3,3-dimethylazetidin-1-yl)-2-oxoethyl]-2-oxo-1,8-naphthyridine-3-carboxamide;N-[(4-chlorophenyl)methyl]-1-[2-(3,3-dimethylazetidin-1-yl)-2-oxoethyl]-6-(imidazol-1-ylmethyl)-2-oxo-1,8-naphthyridine-3-carboxamide;1H-imidazole.

Molecular Properties

Compound Name6-(chloromethyl)-N-[(4-chlorophenyl)methyl]-1-[2-(3,3-dimethylazetidin-1-yl)-2-oxoethyl]-2-oxo-1,8-naphthyridine-3-carboxamide;N-[(4-chlorophenyl)methyl]-1-[2-(3,3-dimethylazetidin-1-yl)-2-oxoethyl]-6-(imidazol-1-ylmethyl)-2-oxo-1,8-naphthyridine-3-carboxamide;1H-imidazole
PubChem CID158180565
Molecular FormulaC54H55Cl3N12O6
Molecular Weight1074.47 g/mol
Exact Mass1072.34
IUPAC Name6-(chloromethyl)-N-[(4-chlorophenyl)methyl]-1-[2-(3,3-dimethylazetidin-1-yl)-2-oxoethyl]-2-oxo-1,8-naphthyridine-3-carboxamide;N-[(4-chlorophenyl)methyl]-1-[2-(3,3-dimethylazetidin-1-yl)-2-oxoethyl]-6-(imidazol-1-ylmethyl)-2-oxo-1,8-naphthyridine-3-carboxamide;1H-imidazole
SMILESCC1(C)CN(C(=O)Cn2c(=O)c(C(=O)NCc3ccc(Cl)cc3)cc3cc(CCl)cnc32)C1.CC1(C)CN(C(=O)Cn2c(=O)c(C(=O)NCc3ccc(Cl)cc3)cc3cc(Cn4ccnc4)cnc32)C1.c1c[nH]cn1
InChIInChI=1S/C27H27ClN6O3.C24H24Cl2N4O3.C3H4N2/c1-27(2)15-33(16-27)23(35)14-34-24-20(9-19(12-30-24)13-32-8-7-29-17-32)10-22(26(34)37)25(36)31-11-18-3-5-21(28)6-4-18;1-24(2)13-29(14-24)20(31)12-30-21-17(7-16(9-25)11-27-21)8-19(23(30)33)22(32)28-10-15-3-5-18(26)6-4-15;1-2-5-3-4-1/h3-10,12,17H,11,13-16H2,1-2H3,(H,31,36);3-8,11H,9-10,12-14H2,1-2H3,(H,28,32);1-3H,(H,4,5)
InChIKeyFYNMXVJCDVPETM-UHFFFAOYSA-N
XLogP7.09
TPSA215.10 Ų
H-Bond Donors3
H-Bond Acceptors13
Rotatable Bonds13
Heavy Atoms75
Complexity—

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5001074.47
LogP ≤ 57.09
H-Bond Donors ≤ 53
H-Bond Acceptors ≤ 1013

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'alkyl_halide', 'substructure': 'N/A'}

Analyze 6-(chloromethyl)-N-[(4-chlorophenyl)methyl]-1-[2-(3,3-dimethylazetidin-1-yl)-2-oxoethyl]-2-oxo-1,8-naphthyridine-3-carboxamide;N-[(4-chlorophenyl)methyl]-1-[2-(3,3-dimethylazetidin-1-yl)-2-oxoethyl]-6-(imidazol-1-ylmethyl)-2-oxo-1,8-naphthyridine-3-carboxamide;1H-imidazole with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 6-(chloromethyl)-N-[(4-chlorophenyl)methyl]-1-[2-(3,3-dimethylazetidin-1-yl)-2-oxoethyl]-2-oxo-1,8-naphthyridine-3-carboxamide;N-[(4-chlorophenyl)methyl]-1-[2-(3,3-dimethylazetidin-1-yl)-2-oxoethyl]-6-(imidazol-1-ylmethyl)-2-oxo-1,8-naphthyridine-3-carboxamide;1H-imidazole?
The IUPAC name of 6-(chloromethyl)-N-[(4-chlorophenyl)methyl]-1-[2-(3,3-dimethylazetidin-1-yl)-2-oxoethyl]-2-oxo-1,8-naphthyridine-3-carboxamide;N-[(4-chlorophenyl)methyl]-1-[2-(3,3-dimethylazetidin-1-yl)-2-oxoethyl]-6-(imidazol-1-ylmethyl)-2-oxo-1,8-naphthyridine-3-carboxamide;1H-imidazole (CID 158180565) is 6-(chloromethyl)-N-[(4-chlorophenyl)methyl]-1-[2-(3,3-dimethylazetidin-1-yl)-2-oxoethyl]-2-oxo-1,8-naphthyridine-3-carboxamide;N-[(4-chlorophenyl)methyl]-1-[2-(3,3-dimethylazetidin-1-yl)-2-oxoethyl]-6-(imidazol-1-ylmethyl)-2-oxo-1,8-naphthyridine-3-carboxamide;1H-imidazole.
What is the SMILES notation for 6-(chloromethyl)-N-[(4-chlorophenyl)methyl]-1-[2-(3,3-dimethylazetidin-1-yl)-2-oxoethyl]-2-oxo-1,8-naphthyridine-3-carboxamide;N-[(4-chlorophenyl)methyl]-1-[2-(3,3-dimethylazetidin-1-yl)-2-oxoethyl]-6-(imidazol-1-ylmethyl)-2-oxo-1,8-naphthyridine-3-carboxamide;1H-imidazole?
The canonical SMILES for 6-(chloromethyl)-N-[(4-chlorophenyl)methyl]-1-[2-(3,3-dimethylazetidin-1-yl)-2-oxoethyl]-2-oxo-1,8-naphthyridine-3-carboxamide;N-[(4-chlorophenyl)methyl]-1-[2-(3,3-dimethylazetidin-1-yl)-2-oxoethyl]-6-(imidazol-1-ylmethyl)-2-oxo-1,8-naphthyridine-3-carboxamide;1H-imidazole is CC1(C)CN(C(=O)Cn2c(=O)c(C(=O)NCc3ccc(Cl)cc3)cc3cc(CCl)cnc32)C1.CC1(C)CN(C(=O)Cn2c(=O)c(C(=O)NCc3ccc(Cl)cc3)cc3cc(Cn4ccnc4)cnc32)C1.c1c[nH]cn1.
What is the InChIKey of 6-(chloromethyl)-N-[(4-chlorophenyl)methyl]-1-[2-(3,3-dimethylazetidin-1-yl)-2-oxoethyl]-2-oxo-1,8-naphthyridine-3-carboxamide;N-[(4-chlorophenyl)methyl]-1-[2-(3,3-dimethylazetidin-1-yl)-2-oxoethyl]-6-(imidazol-1-ylmethyl)-2-oxo-1,8-naphthyridine-3-carboxamide;1H-imidazole?
The InChIKey is FYNMXVJCDVPETM-UHFFFAOYSA-N. The full InChI is InChI=1S/C27H27ClN6O3.C24H24Cl2N4O3.C3H4N2/c1-27(2)15-33(16-27)23(35)14-34-24-20(9-19(12-30-24)13-32-8-7-29-17-32)10-22(26(34)37)25(36)31-11-18-3-5-21(28)6-4-18;1-24(2)13-29(14-24)20(31)12-30-21-17(7-16(9-25)11-27-21)8-19(23(30)33)22(32)28-10-15-3-5-18(26)6-4-15;1-2-5-3-4-1/h3-10,12,17H,11,13-16H2,1-2H3,(H,31,36);3-8,11H,9-10,12-14H2,1-2H3,(H,28,32);1-3H,(H,4,5).
What are the key properties of 6-(chloromethyl)-N-[(4-chlorophenyl)methyl]-1-[2-(3,3-dimethylazetidin-1-yl)-2-oxoethyl]-2-oxo-1,8-naphthyridine-3-carboxamide;N-[(4-chlorophenyl)methyl]-1-[2-(3,3-dimethylazetidin-1-yl)-2-oxoethyl]-6-(imidazol-1-ylmethyl)-2-oxo-1,8-naphthyridine-3-carboxamide;1H-imidazole?
6-(chloromethyl)-N-[(4-chlorophenyl)methyl]-1-[2-(3,3-dimethylazetidin-1-yl)-2-oxoethyl]-2-oxo-1,8-naphthyridine-3-carboxamide;N-[(4-chlorophenyl)methyl]-1-[2-(3,3-dimethylazetidin-1-yl)-2-oxoethyl]-6-(imidazol-1-ylmethyl)-2-oxo-1,8-naphthyridine-3-carboxamide;1H-imidazole has a molecular weight of 1074.47 g/mol, XLogP of 7.09, 13 rotatable bonds, 3 hydrogen bond donors, and 13 hydrogen bond acceptors.
Where does this data come from?
All data for 6-(chloromethyl)-N-[(4-chlorophenyl)methyl]-1-[2-(3,3-dimethylazetidin-1-yl)-2-oxoethyl]-2-oxo-1,8-naphthyridine-3-carboxamide;N-[(4-chlorophenyl)methyl]-1-[2-(3,3-dimethylazetidin-1-yl)-2-oxoethyl]-6-(imidazol-1-ylmethyl)-2-oxo-1,8-naphthyridine-3-carboxamide;1H-imidazole is sourced from PubChem (CID 158180565), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).